Brief: Hlb Inc To Acquire 16 Billion Won Worth Of Shares In Neurotobe Pharmaceuticals Inc
10/09/2024 08:18
HLB Inc 028300.KQ :
* HLB INC: TO ACQUIRE 16 BILLION WON WORTH OF SHARES IN
NEUROTOBE
PHARMACEUTICALS INC
Source text for Eikon: ID:
Further company coverage: 028300.KQ
Recent news on HLB
See all newsBrief: Elevar Therapeutics' NDA Resubmission For Rivoceranib With Camrelizumab Accepted By FDA
Brief: Elevar Therapeutics Resubmits NDA To U.S. FDA For Camrelizumab Plus Rivoceranib Astreatment For Unresectable Hepatocellular Carcinoma
Brief: Hlb Inc To Acquire 16 Billion Won Worth Of Shares In Neurotobe Pharmaceuticals Inc
Health Rounds: Exercise helps with sexual dysfunction after prostate cancer treatment
Brief: HLB Inc Signs 18.5 Billion Won Supply Deal